Canget Bio Tekpharma

Developing cancer-targeting agents with low toxicity and high efficacy

placeBuffalo, New York, United States calendar_todayFounded 2012 groups8 employees language canget-biotek.com

Registered entities

Innovation

2 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace active. Cited 32 times.

YearFilings
20181
20191
20251

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon